These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 2149060

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Proof for piroximone's inotropic influence; can it safely be used in coronary artery disease? Analysis of end-systolic pressure-volume relations (conductance technique).
    Thormann J, Liebrich A, Mitrovic V, Strasser R, Dieterich HA, Schlepper M.
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):50-62. PubMed ID: 1383631
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inotropic effect of enoximone in patients with severe heart failure: demonstration by left ventricular end-systolic pressure-volume analysis.
    Herrmann HC, Ruddy TD, William G, Strauss HW, Boucher CA, Fifer MA.
    J Am Coll Cardiol; 1987 May; 9(5):1117-23. PubMed ID: 2952702
    [Abstract] [Full Text] [Related]

  • 6. [Is the bradycardic effect of tedisamil at the expense of the loss of the inotropic effect? A pressure-volume analysis with the conductance (volume) catheter technique in patients with coronary artery disease].
    Thormann J, Mitrovic V, Strasser R, Pitschner HF, Riedel H, Bahavar H, Schlepper M.
    Z Kardiol; 1993 Apr; 82(4):211-21. PubMed ID: 8506715
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Acute effects of enoximone after intracoronary administration on hemodynamics, myocardial perfusion and regional wall motion].
    Mitrovic V, Strasser R, Berwing K, Thormann J, Schlepper M.
    Z Kardiol; 1996 Nov; 85(11):856-67. PubMed ID: 9064948
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of intracoronary infusion of an inotropic agent, E-1020 (loprinone hydrochloride), on cardiac function: evaluation of left ventricular contractile performance using the end-systolic pressure-volume relationship.
    Murakami R, Sano K, Murakami Y, Shimada T, Morioka S.
    Int J Cardiol; 1995 Aug; 51(1):57-63. PubMed ID: 8522398
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cardiac energetics after intravenous enoximone in idiopathic dilated cardiomyopathy.
    Heiss HW, Hasenfuss G, Holubarsch C, Meinertz T, Just H.
    Am J Cardiol; 1987 Aug 14; 60(5):53C-56C. PubMed ID: 2956869
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Potential mechanisms of improved left ventricular function with enoximone in severe congestive heart failure.
    Chatterjee K, Kereiakes D, Viquerat C, Podolin R.
    Am J Cardiol; 1987 Aug 14; 60(5):37C-41C. PubMed ID: 2956866
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.